Moody's recently announced a joint initiative with MSCI to develop an innovative solution for assessing risks in private credit investments. This collaboration leverages MSCI's vast data repository and Moody's EDF-X models, providing enhanced risk insights and tools for investors. Despite this positive development, Moody's shares declined 2.93% last week, aligning closely with broader market pressures, where major indexes including the Dow Jones and S&P 500 also saw significant declines due to persistent tariff concerns and geopolitical tensions. The market downturn overshadowed Moody's advancements, reflecting investor wariness in a volatile landscape.

You should learn about the 2 risks we've spotted with Moody's.

AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

The recent collaboration between Moody's and MSCI could significantly enhance their capabilities in the burgeoning field of private credit investment risk assessment, potentially bolstering long-term revenue and earnings forecasts. Moody's strategic focus on GenAI and geographic expansion aims to improve operational efficiency and diversify revenue streams, which aligns with the positive outlook prompted by this alliance. Despite an immediate 2.93% share price decline amidst broader market pressures, Moody's shares have appreciated 74.10% over the last five years, reflecting robust investor confidence over the long term.

Over the past year, Moody's performance has been mixed in comparison to the U.S. Capital Markets industry, which saw a return of 14.3%, whereas, Moody's one-year return fell short of this benchmark. However, the long-term growth trajectory, supported by strategic investments and innovations, offers a promising outlook for shareholders. Considering the current share price of US$425.69 against the analyst consensus price target of US$511.42, there is room for potential upside in line with expected revenue and earnings growth of 7.4% annually over the next three years. Investors should closely monitor how the ongoing developments impact revenue streams and match analyst expectations, mindful of the market's broader fluctuations and inherent risks.

Examine Moody's earnings growth report to understand how analysts expect it to perform.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:MCO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com